Meeting Abstract

ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL

Volume: 5 Number: S-1 August 9, 2022
EN TR

ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL

Abstract

Anaplastic thyroid cancer (ATC) is one of the deadliest human malignancies, with no effective treatment, survival limited to a few months. The disease is characterized by a high rate of metastasis and is resistant to almost all available cytotoxic. There is an urgent need for chemicals with an effective, low toxicity profile. Objective: In study, the antimetastatic property of tetrahydrocurcumin (THC), the active metabolite of Curcuma Longa, was compared with docetaxel and the presence of synergism in the combination of the two substances was investigated in vitro. Material and Method: IC25 and IC50 concentrations of THC and (DX) in CAL62 and 8505C cells were determined by modified MTT method we developed in our laboratory. These 2 concentrations were compared with the control in the treatment groups. Cell motility as an indicator of metastatic potential was evaluated by in-vitro wound healing method. Cellular cytotoxicity was evaluated by TAS-TOS analyses. Results: In the 8505C cell line, Total antioxidant status was observed in the DXB-CRC IC50/2 group with a significant statistical increase. THC significantly reduced the oxidative stress index in the highest combination group, especially in DXB. It was found that the combined dose prevented migration and invasion in CAL62 cells in the first hours. There was no difference in Total Oxidant level between the combination and control groups. It was observed that the most effective dose that significantly reduced the oxidative level was DX50. THC in ATK cells has antimetastatic potential close to Docetaxel; It was thought that docetaxel reduced oxidative stress.

Keywords

References

  1. Arayıcı ME YF, Ellidokuz H. Importance of Cancer Registration and its Place in Cancer Control. Sted. 2021;30(5):366-75.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Meeting Abstract

Publication Date

August 9, 2022

Submission Date

July 19, 2022

Acceptance Date

July 19, 2022

Published in Issue

Year 2022 Volume: 5 Number: S-1

APA
Kocdor, M. A., Kaya, Y., Yıldırım, A., & Koçdor, H. (2022). ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL. Journal of Advanced Research in Health Sciences, 5(S-1), 61-61. https://doi.org/10.26650/JARHS2021-1145546
AMA
1.Kocdor MA, Kaya Y, Yıldırım A, Koçdor H. ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL. Journal of Advanced Research in Health Sciences. 2022;5(S-1):61-61. doi:10.26650/JARHS2021-1145546
Chicago
Kocdor, Mehmet Alı, Yagmur Kaya, Arzu Yıldırım, and Hilal Koçdor. 2022. “ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL”. Journal of Advanced Research in Health Sciences 5 (S-1): 61-61. https://doi.org/10.26650/JARHS2021-1145546.
EndNote
Kocdor MA, Kaya Y, Yıldırım A, Koçdor H (August 1, 2022) ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL. Journal of Advanced Research in Health Sciences 5 S-1 61–61.
IEEE
[1]M. A. Kocdor, Y. Kaya, A. Yıldırım, and H. Koçdor, “ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL”, Journal of Advanced Research in Health Sciences, vol. 5, no. S-1, pp. 61–61, Aug. 2022, doi: 10.26650/JARHS2021-1145546.
ISNAD
Kocdor, Mehmet Alı - Kaya, Yagmur - Yıldırım, Arzu - Koçdor, Hilal. “ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL”. Journal of Advanced Research in Health Sciences 5/S-1 (August 1, 2022): 61-61. https://doi.org/10.26650/JARHS2021-1145546.
JAMA
1.Kocdor MA, Kaya Y, Yıldırım A, Koçdor H. ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL. Journal of Advanced Research in Health Sciences. 2022;5:61–61.
MLA
Kocdor, Mehmet Alı, et al. “ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL”. Journal of Advanced Research in Health Sciences, vol. 5, no. S-1, Aug. 2022, pp. 61-61, doi:10.26650/JARHS2021-1145546.
Vancouver
1.Mehmet Alı Kocdor, Yagmur Kaya, Arzu Yıldırım, Hilal Koçdor. ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXEL. Journal of Advanced Research in Health Sciences. 2022 Aug. 1;5(S-1):61-. doi:10.26650/JARHS2021-1145546